Rare diseases
Investigational molecules
Locations
Clinical trials in France – page 54 188 clinical trials in France across 198 research sites in 379 cities. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceFranceWhere most of the country's trials are run
Shares are of these cities' trials together.
379 cities, A–Z – pick yours to filter the trials
What the registry says about research in the country
France is conducting extensive clinical research in oncology, focusing on a wide range of malignancies. Trials investigate treatments for non-small cell lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, and various hematological malignancies including acute myeloid leukemia, multiple myeloma, and lymphomas. Research emphasizes novel immunotherapies, targeted therapies, and combination treatment approaches.
Studies aim to improve survival rates, disease control, and quality of life through innovative therapeutic combinations and personalized medicine approaches based on molecular profiling.
Clinical trials in France address numerous autoimmune conditions and inflammatory disorders. Research focuses on rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel diseases (Crohn's disease, ulcerative colitis), psoriasis, psoriatic arthritis, and multiple sclerosis. Investigations evaluate biologic therapies, small molecule inhibitors, and immunomodulatory agents.
These trials seek to achieve disease remission, reduce symptom burden, and minimize long-term complications while optimizing safety profiles.
French clinical research addresses major cardiovascular conditions including heart failure, atrial fibrillation, acute coronary syndromes, and atherosclerotic cardiovascular disease. Studies investigate preventive strategies, acute interventions, and chronic disease management. Research includes lipid-lowering therapies, anticoagulation strategies, and treatments for heart failure with preserved ejection fraction.
The research aims to reduce cardiovascular mortality, prevent major adverse cardiac events, and improve functional outcomes in patients with heart disease.
Neurological research in France encompasses Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and various neuromuscular disorders. Trials evaluate disease-modifying therapies, symptomatic treatments, and neuroprotective strategies. Studies address cognitive decline, motor symptoms, and neuroinflammation across different neurological conditions.
Research focuses on slowing disease progression, improving quality of life, and developing biomarkers for early diagnosis and treatment monitoring.
Clinical trials investigate treatments for asthma, chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis, and other interstitial lung diseases. Research evaluates biologic therapies for severe asthma, antifibrotic agents, and treatments for pulmonary hypertension. Studies also address cystic fibrosis and rare respiratory conditions.
The research aims to improve lung function, reduce exacerbations, and enhance quality of life in patients with chronic respiratory conditions.
French research addresses various bacterial, viral, and fungal infections. Studies focus on antimicrobial resistance, hospital-acquired infections, HIV, hepatitis viruses, and emerging infectious diseases. Research includes novel antibiotics, antiviral agents, immunotherapies, and vaccination strategies.
Trials aim to improve treatment outcomes, reduce transmission, and develop effective prevention strategies for infectious diseases.
Research addresses hemophilia, sickle cell disease, thalassemia, immune thrombocytopenia, and various coagulation disorders. Studies evaluate gene therapies, novel replacement factors, and treatments for hemolytic anemias. Research also includes thrombotic disorders and platelet dysfunction.
The research seeks to reduce bleeding episodes, improve quality of life, and develop curative approaches for inherited blood disorders.
Clinical trials investigate chronic kidney disease, glomerulonephritis, IgA nephropathy, lupus nephritis, and kidney transplantation. Research evaluates therapies to slow disease progression, reduce proteinuria, and prevent end-stage renal disease. Studies also address acute kidney injury and complications of kidney disease.
Research aims to preserve kidney function, reduce the need for dialysis, and improve outcomes in kidney transplant recipients.
France conducts significant research on rare diseases including muscular dystrophies, metabolic disorders, lysosomal storage diseases, and various genetic syndromes. Studies evaluate enzyme replacement therapies, gene therapies, and substrate reduction approaches. Research addresses conditions like spinal muscular atrophy, Duchenne muscular dystrophy, and Fabry disease.
Trials focus on slowing disease progression, improving functional outcomes, and addressing the underlying genetic causes of these conditions.
Clinical research addresses atopic dermatitis, psoriasis, hidradenitis suppurativa, vitiligo, and various inflammatory skin conditions. Studies evaluate biologic therapies, topical treatments, and systemic immunomodulators. Research also includes skin cancers and rare dermatological disorders.
The research aims to achieve disease control, improve quality of life, and reduce the burden of chronic skin diseases.
French research investigates treatments for age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and inherited retinal diseases. Studies evaluate anti-VEGF therapies, gene therapies, and novel approaches for dry AMD and geographic atrophy. Research also addresses glaucoma and uveitis.
Trials focus on preserving vision, slowing disease progression, and developing curative approaches for previously untreatable conditions.
Research addresses inflammatory bowel diseases, liver cirrhosis, non-alcoholic steatohepatitis, viral hepatitis, and gastrointestinal cancers. Studies evaluate immunomodulators, antifibrotic therapies, and treatments for portal hypertension. Research includes hepatocellular carcinoma and complications of chronic liver disease.
Trials aim to achieve mucosal healing, prevent disease progression, and reduce complications of chronic gastrointestinal and liver diseases.
Clinical trials investigate diabetes, obesity, thyroid disorders, and various endocrine conditions. Research evaluates novel glucose-lowering therapies, weight management strategies, and treatments for metabolic syndrome. Studies address growth disorders, adrenal insufficiency, and rare endocrine tumors.
Research focuses on glycemic control, weight reduction, and prevention of long-term complications of metabolic diseases.
French research addresses pediatric conditions including childhood cancers, genetic disorders, autoimmune diseases, and developmental disorders. Studies evaluate age-appropriate formulations, dosing strategies, and safety profiles in children. Research includes juvenile idiopathic arthritis, pediatric inflammatory bowel disease, and rare pediatric conditions.
Trials aim to improve outcomes while considering the unique physiological and developmental needs of pediatric populations.
Research addresses sepsis, acute respiratory distress syndrome, traumatic injury, and various critical care conditions. Studies evaluate hemodynamic support, mechanical ventilation strategies, and treatments for organ failure. Research includes cardiac arrest, shock states, and acute neurological emergencies.
Trials focus on reducing mortality, preventing organ dysfunction, and improving long-term outcomes in critically ill patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
